Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Tot Biopharm International Co Ltd (1875)

Hong Kong
Currency in HKD
Disclaimer
1.68
+0.10(+6.33%)
Closed
1875 Scorecard
Fair Value
Unlock Value
Day's Range
1.531.68
52 wk Range
0.803.40
Bid/Ask
1.55 / 1.69
Prev. Close
1.58
Open
1.58
Day's Range
1.53-1.68
52 wk Range
0.8-3.4
Volume
32,800
Average Vol. (3m)
45,185
1-Year Change
-20.38%
Shares Outstanding
772,787,887
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
How do you feel today about 1875?
Vote to see community's results!
or

Tot Biopharm International Co Ltd Company Profile

TOT BIOPHARM International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in China. The company develops TAB008 for the treatment of non-squamous non-small-cell lung cancer, metastatic colorectal cancer, glioblastoma multiforme, ovarian cancer, cervical cancer, fallopian tube cancer, or primary peritoneal cancer, and hepatocellular carcinoma. It also offers TOZ309 for the treatment of glioblastoma multiforme or anaplastic astrocytoma. In addition, the company develops TAA013 for HER2+ breast cancer; TAE020 which is under preclinical trial for acute myeloid leukemia; and TAB014 for wet age-related macular degeneration. Further it develops TAC020 for the treatment various solid tumors. TOT BIOPHARM International Company Limited was incorporated in 2009 and is headquartered in Suzhou, China.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.